1. Ofatumumab for refractory opsoclonus‐myoclonus syndrome following treatment of neuroblastoma. Issue 12 (29th June 2013) Authors: Ketterl, Tyler G.; Messinger, Yoav H.; Niess, Dawn R.; Gilles, Elizabeth; Engel, William Keith; Perkins, Joanna L. Journal: Pediatric blood & cancer Issue: Volume 60:Issue 12(2013:Dec.) Page Start: E163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Skin and self‐injury: a possible link between peripheral innervation and immune function?. (4th September 2014) Authors: Symons, Frank J; Gilles, Elizabeth; Tervo, Raymond; Wendelschafer‐Crabb, Gwen; Panoutsopoulou, Ioanna; Kennedy, William Journal: Developmental medicine & child neurology Issue: Volume 57:Number 7(2015:Jul.) Page Start: 677 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Switching the Smoothened Inhibitor May Have Benefit in Advanced Basal Cell Carcinoma. (May 2018) Authors: Khalid, Bilal; Mukherjee, Sarbajit; Ibrahimi, Sami; Cannon, Trinitia; Gilles, Elizabeth; Moreau, Annie; Razaq, Mohammad Journal: American journal of therapeutics Issue: Volume 25:Number 3(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗